Zhihui Liang

Zhihui Liang

Auto-generated profile, based on publicly available information

Zhihui Liang

School of Chemical Engineering Dalian University of Technology Dalian China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2022 in ACS Nano
Verified
Journal Article
Closed access
MLMin Li
Min Li
ZLZhihui Liang
Zhihui Liang
CCChen Chen
Chen Chen
GYGe Yu
Ge Yu
ZYZhiying Yao
Zhiying Yao
Bingbing SunBingbing Sun
Bingbing Sun

14 March 2025 in Smart Molecules
Verified
Journal Article
Open access
XWXin Wang
Xin Wang
HLHaoyu Li
Haoyu Li
CCChen Chen
Chen Chen
ZLZhihui Liang
Zhihui Liang
Emerging therapies rely on the efficient and specific delivery of targeted agents into the cytosol, such as DNA, siRNA and proteins. Nanoparticles showed great potentials in safe delivery and transportation of the targeted cargoes; however, the entrapment in endosomes and degradation by specific enzymes in the lysosome hindered the bioavailability, cytosolic delivery and subsequent therapeutic efficacy. In this case, the development of methods for efficient and specific delivery of targeted therapeutic agents focuses on overcoming the major challenge of endo/lysosomal escape, which relies on the development of safe and efficient nano‐delivery systems. A deeper mechanistic understanding in the endo/lysosomal escape will guide the development of more efficient nano‐delivery systems. In this review, we summarize various mechanisms by which nanoparticles escape from the endo/lysosome, and showcase the recent progress in dissecting the endo/lysosomal approaches based on nano‐delivery systems. Emphasis will lie on the properties of nanoparticles that govern the endo/lysosomal escape pathway as well as the latest promising applications in vaccine delivery and genetic engineering field.

12 September 2024 in Advanced Materials
Verified
Journal Article
Open access
YXYu Xiao
Yu Xiao
ZLZhihui Liang
Zhihui Liang
MSMoldir Shyngys
Moldir Shyngys
ABAiana Baekova
Aiana Baekova
SCSuen Cheung
Suen Cheung
Chung Hang Jonathan ChoiChung Hang Jonathan Choi
Chung Hang Jonathan Choi
Nucleic acid nanostructures, derived from the assembly of nucleic acid building blocks (e.g., plasmids and oligonucleotides), are important intracellular carriers of therapeutic cargoes widely utilized in preclinical nanomedicine applications, yet their clinical translation remains scarce. In the era of “translational nucleic acid nanotechnology”, a deeper mechanistic understanding of the interactions of nucleic acid nanostructures with cells in vivo will guide the development of more efficacious nanomedicines. This review showcases the recent progress in dissecting the in vivo interactions of four key types of nucleic acid nanostructures (i.e., tile‐based, origami, spherical nucleic acid, and nucleic acid nanogel) with cells in rodents over the past five years. Emphasis lies on the cellular‐level distribution of nucleic acid nanostructures in various organs and tissues and the cellular responses induced by their cellular entry. Next, in the spirit of preclinical translation, this review features the latest interactions of nucleic acid nanostructures with cells in large animals and humans. Finally, the review offers directions for studying the interactions of nucleic acid nanostructures with cells from both materials and biology perspectives and concludes with some regulatory updates.

12 December 2021 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
LZLei Zhang
Lei Zhang
ZLZhihui Liang
Zhihui Liang
CCChen Chen
Chen Chen
XYXuecheng Yang
Xuecheng Yang
DFDuo Fu
Duo Fu
Bingbing SunBingbing Sun
Bingbing Sun

14 August 2022 in Biomaterials
Verified
Journal Article
Closed access
DFDuo Fu
Duo Fu
MWMengjia Wang
Mengjia Wang
TYTao Yang
Tao Yang
MLMin Li
Min Li
ZLZhihui Liang
Zhihui Liang
Chuanbin MaoChuanbin Mao
Chuanbin Mao